“Follow for more life-saving tips”- 🫀🩺⛑️🥼🧠
35y old patient has palpitations, light-headedness, and stable tachycardia. The monitor shows a regular narrow-complex QRS at a rate of 180/min. Vagal maneuvers hand not bend effective in terminating the rhythm. An IV has been established.
In my experience working with patients presenting with stable narrow-complex tachycardia, it's crucial to understand both the symptoms and appropriate interventions to ensure timely reversal of the arrhythmia. This condition, often characterized by palpitations and light-headedness, can distress patients significantly and requires swift assessment. When dealing with a regular narrow-complex tachycardia at a rate of around 180/min, initial vagal maneuvers are the first line to attempt termination. However, as highlighted, these may not always be successful. An important next step is the administration of adenosine, typically starting at a 6 mg rapid IV bolus. Adenosine works by transiently blocking atrioventricular (AV) nodal conduction, which can interrupt the reentrant pathway causing the tachycardia. It is also important to note why other drugs may not be suitable initially: atropine is generally used in bradycardia rather than tachycardia; epinephrine is reserved for specific emergency scenarios such as cardiac arrest and not for stable tachyarrhythmias. From my hands-on experiences, having immediate IV access is key to delivering adenosine quickly, as its effect is very brief but effective when administered correctly. Patients often feel a brief flushing sensation or chest discomfort, but these effects are transient and confirm the drug's activity. Ultimately, recognizing the clinical scenario—narrow complex, stable tachycardia unresponsive to vagal stimulation—and promptly using adenosine can be life-saving. It underscores the importance of high-quality CPR services and emergency readiness. Sharing these insights and continual education helps ensure better outcomes in cardiac emergencies. For those interested in advanced cardiac life support, understanding the pharmacology and application of adenosine remains a cornerstone in managing supraventricular tachycardias.
































































































